Mode of action of empagliflozin to prevent heart failure
20 May 2024Identifying proteins and pathways that drive one drug’s mechanism of action can further the understanding of multiple diseases, and may point to new therapeutics. Olink describes the mode of action of empagliflozin in preventing heart failure, highlighting insights derived from completed clinical trial samples, such as the EMPEROR STUDY, a clinical trial using 1,134 patient samples in a continuous study at weeks 0, 12, and 52 using Olink Explore®.
Links
Tags
Data AnalysisData analysis hardware and software is available to make data processing straight-forward yet powerful. Data software can be used for math and stats, technical graphing and image analysis. In addition, software is available for specific data analysis of electrophoresis, densitometry, ELISA and DNA sequencing.Clinical TrialsClinical Trials, an essential part of drug discovery process, assess the safety and effectiveness of a new medication or device in the pharmaceutical industry. Clinical Trials are a phased process (Phase 0, Phase I, Phase II, Phase III and Phase IV) which begins after initial preclinical testing.Clinical StudyProspective biomedical or behavioral research studies on human subjects, following tests in animals, that are designed to answer specific questions about novel vaccines, drugs, treatments, dietary supplements, devices or new ways of using known interventions, generating safety and efficacy data.